https://www.selleckchem.com/pr....oducts/ly2090314.htm
The interplay between HCV, DM, and DAA therapy is poorly understood. We compared HCV infection characteristics, treatment uptake, and treatment outcomes in patients with and without DM. METHODS A retrospective cohort study was conducted using data from The Ottawa Hospital Viral Hepatitis Program. Statistical comparisons between diabetes and non-diabetes were made using χ and t-tests. Logistic regression analyses were performed to assess predictors of DM and SVR. One thousand five hundred eighty-eight HCV patients were included in this